The Online Books Page

Books by Center for Drugs and Biologics (U.S.):

Books in the extended shelves:

• Center for Drugs and Biologics (U.S.): Anesthesia and sedation in the dental office. (U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, Office of Medical Applications of Research, 1985), also by Md.) NIH Consensus Development Conference Anesthesia and Sedation in the Dental Office (1985 : Bethesda, National Institute of Dental Research (U.S.), and National Institutes of Health (U.S.). Office of Medical Applications of Research (page images at HathiTrust)
• Center for Drugs and Biologics (U.S.): Compliance program reference : inspections of licensed and unlicensed blood banks (compliance program #7342.001) and inspections of source plasma establishments (compliance program #7342.002). (Center for Drugs and Biologics, 1985) (page images at HathiTrust)
• Center for Drugs and Biologics (U.S.): Compliance program reference : OTC drug monograph implementation (compliance program #7361.003). ([Center for Drugs and Biologics], 1985) (page images at HathiTrust)
• Center for Drugs and Biologics (U.S.): Drug and device product approvals. (Food and Drug Administration., in the 1970s), also by Center for Drug Evaluation and Research (U.S.). Division of Drug Information Resources, Center for Veterinary Medicine (U.S.), and Center for Devices and Radiological Health (U.S.) (page images at HathiTrust)
• Center for Drugs and Biologics (U.S.): Guideline for submitting documentation for packaging for human drugs and biologics (U. S. Dept. of Health and Human Services, 1987) (page images at HathiTrust)
• Center for Drugs and Biologics (U.S.): Guideline for submitting documentation for packaging for human drugs and biologics (Datapharm Information Services, Division of Interpharm Press, 1987) (page images at HathiTrust)
• Center for Drugs and Biologics (U.S.): Guideline for submitting documentation for the manufacture of and controls for drug products. (Center for Drugs and Biologics, Food and Drug Administration, Dept. of Health and Human Services, 1987) (page images at HathiTrust)
• Center for Drugs and Biologics (U.S.): Guideline for submitting documentation for the stability of human drugs and biologics. (Datapharm Information Services, Division of Interpharm Press, 1987), also by United States Food and Drug Administration (page images at HathiTrust)
• Center for Drugs and Biologics (U.S.): Guideline for submitting samples and analytical data for methods validation. (Food and Drug Administration, Center for Drugs and Biologics, Dept. of Health and Human Services, 1987) (page images at HathiTrust)
• Center for Drugs and Biologics (U.S.): Guideline for submitting samples and analytical data for methods validation. (Datapharm Information Services, Division of Interpharm Press, 1987), also by United States Food and Drug Administration (page images at HathiTrust)
• Center for Drugs and Biologics (U.S.): Guideline for submitting supporting documentation in drug applications for the manufacture of drug substances (U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, 1987) (page images at HathiTrust)
• Center for Drugs and Biologics (U.S.): Guideline for the format and content of the chemistry, manufacturing, and controls section of an application. (Center for Drugs and Biologics, Food and Drug Administration, Dept. of Health and Human Services, 1987) (page images at HathiTrust)
• Center for Drugs and Biologics (U.S.): Guideline for the format and content of the human pharmacokinetics and bioavailability section of an application. (Center for Drugs and Biologics, Food and Drug Administration, Dept. of Health and Human Services, 1987) (page images at HathiTrust)
• Center for Drugs and Biologics (U.S.): Guideline for the format and content of the nonclinical pharmacology/toxicology section of an application. (Center for Drugs and Biologics, Food and Drug Administration, Dept. of Health and Human Services, 1987) (page images at HathiTrust)
• Center for Drugs and Biologics (U.S.): Guideline for the format and content of the summary for new drug and antibiotic applications. (Center for Drugs and Biologics, Food and Drug Administration, Dept. of Health and Human Services, 1987) (page images at HathiTrust)
• Center for Drugs and Biologics (U.S.): Guideline on formatting, assembling, and submitting new drug and antibiotic applications. (Center for Drugs and Biologics, Food and Drug Administration, Dept. of Health and Human Services, 1987) (page images at HathiTrust)
• Center for Drugs and Biologics (U.S.): Guideline on general principles of process validation (U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, 1987), also by Center for Devices and Radiological Health (U.S.) (page images at HathiTrust)
• Center for Drugs and Biologics (U.S.): Guideline on sterile drug products produced by aseptic processing (U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, 1987), also by Center for Drugs and Biologics (U.S.). Office of Compliance. Division of Manufacturing and Product Quality and United States. Food and Drug Administration. Office of Regulatory Affairs (page images at HathiTrust)
• Center for Drugs and Biologics (U.S.): Guidelines for the time frame applicable to the review and approval of new drug applications and antibiotic applications. (Datapharm Information Services, Division of Interpharm Press, 1985), also by United States Food and Drug Administration (page images at HathiTrust)
• Center for Drugs and Biologics (U.S.): Orange book (U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Drugs and Biologics ;, 1985), also by Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs, Center for Drug Evaluation and Research (U.S.). Division of Data Management and Services, Center for Drug Evaluation and Research (U.S.). Division of Drug Information Resources, Center for Drug Evaluation and Research (U.S.). Office of Management, and Center for Drug Evaluation and Research (U.S.) (page images at HathiTrust)

Find more by Center for Drugs and Biologics (U.S.) at your library, or elsewhere.